ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173905 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173905; 2) Community: the network communities that were significantly associated with the response to NSC 173905; 3) Molecule: the relationships between components within communities and NSC 173905; 4) MDR: the compounds that were significantly associated with the NSC 173905.

NSC Compound Enrichment Correlation
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.0461160768969335 0.23956574
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.0461160768969335 0.2676
NSC 671456 3-(4-Fluorophenyl)-3-(4-acetoxy-2-methylphenyl)phthalide 0.0461160768969335 -0.10972926
NSC 682237 Null 0.0461160768969335 -0.033078647
NSC 683555 Camptothecin Derivative 0.0461160768969335 0.23505285
NSC 683628 Null 0.0461160768969335 0.21920429
NSC 687006 Null 0.0461160768969335 0.29766991
NSC 689530 Null 0.0461160768969335 0.37758354
NSC 690266 ANTINEOPLASTIC-690266 0.0461160768969335 0.50252432
NSC 693984 Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-propynyl-, (E)- 0.0461160768969335 0.5322844
Total:116  Current:112    [First] [Prev] [Next] [Last]